| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.0M | -78.2% |
| Cost of Revenue | $651K | -88.8% |
| Gross Profit | $3.4M | -73.3% |
| R&D Expense | $31.5M | +11.6% |
| SG&A Expense | $6.3M | -32.8% |
| Operating Income | -$34.5M | -37.5% |
| Pre-tax Income | -$33.6M | -31.9% |
| Income Tax | -$688K | +91.4% |
| Net Income | -$32.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $157.3M | -33.6% |
| Short-term Investments | $60.2M | — |
| Current Assets | $219.8M | -10.9% |
| Total Assets | $246.1M | -10.6% |
| Current Liabilities | $4.1M | +17.8% |
| Total Liabilities | $5.7M | -1.6% |
| Stockholders' Equity | $240.4M | -10.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | -121.3% |
| Capital Expenditures | $585K | -83.4% |
| Investing Cash Flow | -$63.9M | -1712.5% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | -$15.4M | -123.4% |
| -88.9% |
| EPS (Basic) | -$1.08 | -86.2% |
| EPS (Diluted) | -$1.08 | -86.2% |